1. Home
  2. BIOX vs CRVO Comparison

BIOX vs CRVO Comparison

Compare BIOX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$1.51

Market Cap

109.2M

Sector

Industrials

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$8.73

Market Cap

89.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
CRVO
Founded
2001
2001
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.2M
89.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIOX
CRVO
Price
$1.51
$8.73
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$4.42
$21.50
AVG Volume (30 Days)
416.3K
84.8K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,158,904.00
$6,159,786.00
Revenue This Year
$1.25
N/A
Revenue Next Year
$27.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$1.80
52 Week High
$7.44
$16.94

Technical Indicators

Market Signals
Indicator
BIOX
CRVO
Relative Strength Index (RSI) 42.13 54.26
Support Level $1.40 $7.80
Resistance Level $1.67 $9.22
Average True Range (ATR) 0.12 0.72
MACD -0.00 -0.03
Stochastic Oscillator 30.10 52.22

Price Performance

Historical Comparison
BIOX
CRVO

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: